Current Rheumatology Reports

, 15:332

Clinical Management of Septic Arthritis

  • Katie A. Sharff
  • Eric P. Richards
  • John M. Townes
INFECTIONS AND ARTHRITIS (K WINTHROP, SECTION EDITOR)

DOI: 10.1007/s11926-013-0332-4

Cite this article as:
Sharff, K.A., Richards, E.P. & Townes, J.M. Curr Rheumatol Rep (2013) 15: 332. doi:10.1007/s11926-013-0332-4
Part of the following topical collections:
  1. Topical Collection on Infections and Arthritis

Abstract

Septic arthritis is a rheumatologic emergency as joint destruction occurs rapidly and can lead to significant morbidity and mortality. Accurate diagnosis can be particularly challenging in patients with underlying inflammatory joint disease. This review outlines the risk factors for septic arthritis and summarizes the causative bacterial organisms. We highlight advances in antibiotic management with a focus on new drugs for methicillin-resistant Staphylococcus aureus (MRSA) and discuss the use of adjunctive therapies for treatment of septic arthritis in adults.

Keywords

Septic arthritisClinical managementAntibiotic managementDiagnosisTreatmentJoint drainageProsthetic joint infectionsSteroidsMRSABisphosphonatesRisk factorsLinezolidDaptomycinCeftarolineQuinupristin-dalfopristin

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Katie A. Sharff
    • 1
  • Eric P. Richards
    • 1
  • John M. Townes
    • 1
  1. 1.Division of Infectious DiseasesOregon Health and Science UniversityPortlandUSA